2024-2029 STRATEGIC PLAN
Our 2024-2029 Strategic Plan provides a roadmap for our future growth and development, and establishes specific, measurable objectives that guides the activities of Breast Cancer Trials (BCT) for the next five years.
The BCT Board of Directors approved the plan in 2024, which highlights our long-term vision and mission, ensuring that all stakeholders understand and work towards common goals.
This will be an exciting time for the organisation, as we prioritise research in key areas of need and seek additional support from the community so that we can do more clinical trials for the benefit of all breast cancer patients.
Pictured: Dr Gabrielle Metz is a 2025 Breast Cancer Trials Clinical Fellow.
OUR VISION
No More Lives Cut Short From Breast Cancer.
OUR MISSION
Do the research that will create solutions for every person, every situation, every time.
OUR VALUES
We Before Me, Curiosity, Empathy and Greatness.
STRATEGIC GOALS
Make meaningful impact by creating the scientific evidence needed for change
Increase the pace of research
Secure the funding needed to prevent research delays and accelerate breakthrough discoveries
STRATEGIC FOCUS
Lead clinical trials in the areas of greatest patient need and potential impact.
Increase clinical trial participation and accessibility.
Collaborate widely with the best minds and leaders in breast cancer research.
Build our community of supporters and inspire their giving to make more research possible.
Build organisational capability and capacity to increase and maximise our research outputs.
Embed technology and systems to enhance operational agility and responsiveness to opportunity.